Kinney Horn
Known title: CHIEF BUSINESS OFFICERCIK: 0001831215
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 15, 2026
OLMA Joins 12 Healthcare Stocks Moving in Pre-Market. OLMA was among 12 healthcare stocks that moved in Wednesday's pre‑market session, signaling early interest from traders. The move comes while the stock sits near its 52‑week low and a low RSI of 19.1, suggesting it may be oversold. This early activity could reflect new market sentiment or a reaction to broader healthcare sector dynamics.
Transaction History
| IMNM | ▲ Buy | Option Exercise | 50,366 | $651K | 8/4/2026 | View on chart |
| IMNM | ▲ Buy | Option Exercise | 40,250 | $427K | 8/4/2026 | View on chart |
| IMNM | ▼ Sell | Open Market | 90,616 | $2.3M | 8/4/2026 | View on chart |
| IMNM | ▲ Buy | Grant | 31,250 | $0 | 7/23/2026 | View on chart |
| IMNM | ▲ Buy | Option Exercise | 1,092 | $14K | 7/7/2026 | View on chart |
| IMNM | ▼ Sell | Open Market | 1,092 | $27K | 7/7/2026 | View on chart |
| OLMA | ▲ Buy | Option Exercise | 5,253 | $11K | 3/10/2022 | View on chart |
| OLMA | ▼ Sell | Open Market | 5,253 | $25K | 3/10/2022 | View on chart |
| OLMA | ▲ Buy | Option Exercise | 5,251 | $11K | 2/10/2022 | View on chart |
| OLMA | ▼ Sell | Other | 5,251 | — | 2/10/2022 | View on chart |
| OLMA | ▲ Buy | Option Exercise | 5,251 | $11K | 1/10/2022 | View on chart |
| OLMA | ▼ Sell | Open Market | 5,251 | $36K | 1/10/2022 | View on chart |
| OLMA | ▲ Buy | Option Exercise | 5,251 | $11K | 12/10/2021 | View on chart |
| OLMA | ▼ Sell | Open Market | 5,251 | $55K | 12/10/2021 | View on chart |
| OLMA | ▲ Buy | Option Exercise | 5,251 | $11K | 11/10/2021 | View on chart |
| OLMA | ▲ Buy | Option Exercise | 22,417 | $426K | 11/10/2021 | View on chart |
| OLMA | ▼ Sell | Open Market | 27,668 | $744K | 11/10/2021 | View on chart |
| OLMA | ▼ Sell | Open Market | 2,105 | $58K | 10/11/2021 | View on chart |
| OLMA | ▼ Sell | Open Market | 3,146 | $89K | 10/11/2021 | View on chart |
| OLMA | ▲ Buy | Option Exercise | 5,251 | $11K | 10/11/2021 | View on chart |
| OLMA | ▲ Buy | Option Exercise | 5,251 | $11K | 9/10/2021 | View on chart |
| OLMA | ▼ Sell | Open Market | 5,251 | $154K | 9/10/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 12, 2026
Immunome files Nasdaq inducement grant report, sees higher volume
Immunome disclosed inducement grants in a filing required by Nasdaq Listing Rule 5635(c)(4). The disclosure shows the company is meeting reporting obligations for equity compensation. At the same time, the stock appeared among Benzinga’s recent volume movers, indicating a noticeable increase in trading activity. These items together suggest regulatory compliance and heightened market attention.
Immunome files Nasdaq inducement grant report, sees higher volume. Immunome disclosed inducement grants in a filing required by Nasdaq Listing Rule 5635(c)(4). The disclosure shows the company is meeting reporting obligations for equity compensation. At the same time, the stock appeared among Benzinga’s recent volume movers, indicating a noticeable increase in trading activity. These items together suggest regulatory compliance and heightened market attention.